Spondyloarthritis (SpA)
12
7
7
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases
Pain in Inflammatory Joint Diseases
Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA
COMFI - a COMbined Fatigue Intervention
AutoInflammatory Disease Alliance Registry (AIDA)
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Vunakizumab in Adults with Spondyloarthritis
A Clinical Study to Evaluate the Efficacy of Biologics in SpA
Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics